Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-22-000214
Filing Date
2022-02-11
Accepted
2022-02-11 16:48:33
Documents
2
Group Members
ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss792530_sc13ga.htm SC 13G/A 52772
2 JOINT FILING AGREEMENT ss792530_ex99a.htm EX-99.A 9598
  Complete submission text file 0000947871-22-000214.txt   63944
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: SC 13G/A | Act: 34 | File No.: 005-89153 | Film No.: 22622076
SIC: 2834 Pharmaceutical Preparations